tiprankstipranks
Novartis (CH:NOVN)
:NOVN
Switzerland Market

Novartis AG (NOVN) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
17Bullish
5Neutral
0Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Novartis’s (NOVN) Moving Averages Convergence Divergence (MACD) indicator is 1.20, suggesting Novartis is a Buy.
Novartis’s (NOVN) 20-Day exponential moving average is 97.27, while Novartis’s (NOVN) share price is CHF98.62, making it a Buy.
Novartis’s (NOVN) 50-Day exponential moving average is 94.82, while Novartis’s (NOVN) share price is CHF98.62, making it a Buy.

Novartis AG (NOVN) Pivot Points

Mar 31, 2025, 02:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
95.22
95.96
97.13
97.87
99.04
99.78
100.95
Fibonacci
95.96
96.69
97.14
97.87
98.60
99.05
99.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novartis AG (NOVN) Moving Averages

Mar 31, 2025, 02:43 AM
Period
Simple
Exponential
MA5
98.04Buy
98.26Buy
MA10
98.45Buy
98.05Buy
MA20
97.46Buy
97.27Buy
MA50
94.24Buy
94.82Buy
MA100
90.73Buy
93.00Buy
MA200
92.67Buy
92.24Buy
Novartis’s (NOVN) 10-Day exponential moving average is 98.05, while Novartis’s (NOVN) share price is CHF98.62, making it a Buy.
Novartis’s (NOVN) 100-Day exponential moving average is 93.00, while Novartis’s (NOVN) share price is CHF98.62, making it a Buy.
Novartis’s (NOVN) stock price is CHF98.62 and Novartis’s (NOVN) 50-day simple moving average is 94.24, creating a Buy signal.
Novartis’s (NOVN) stock price is CHF98.62 and Novartis’s (NOVN) 100-day simple moving average is 90.73, creating a Buy signal.
Novartis’s (NOVN) stock price is CHF98.62 and Novartis’s (NOVN) 200-day simple moving average is 92.67, creating a Buy signal.

Novartis AG (NOVN) Technical Indicators

Mar 31, 2025, 02:43 AM
Name
Value
Implied Action
RSI (14)
59.44
Neutral
STOCH (9,6)
55.21
Neutral
STOCHRSI (14)
48.86
Neutral
MACD (12,26)
1.20
Buy
ADX (14)
17.94
Buy
Williams %R
-29.03
Buy
CCI (14)
42.37
Neutral
ATR (14)
2.48
-
Ultimate Oscillator
50.06
Neutral
ROC
0.76
Buy
Novartis’s (NOVN) Relative Strength Index (RSI) is 59.44, creating a Neutral signal.
Novartis’s (NOVN) Trend Strength Indicator (ADX) is 17.94, creating a Buy signal.
Novartis’s (NOVN) Commodity Channel Index (CCI) is 42.37, creating a Neutral signal.
Novartis’s (NOVN) Price Rate of Change (ROC) is 0.76, creating a Buy signal.

FAQ

Is NOVN a Buy, Hold, or Sell?
Based on NOVN’s technical indicators, NOVN is a Strong Buy.
    What is NOVN’s RSI (14)?
    NOVN’s RSI (14) is 59.44, which suggests NOVN is a Neutral.
      What is NOVN’s MACD?
      NOVN’s MACD is 1.20, which suggests NOVN is a Buy.
        What is NOVN’s 5-day moving average?
        NOVN’s 5-day moving average is 98.04, which suggests NOVN is a Buy.
          What is NOVN’s 20-day moving average?
          NOVN 20-day moving average is 97.46, which suggests NOVN is a Buy.
            What is NOVN’s 50-day moving average?
            NOVN’s 50-day moving average is 94.24, which suggests NOVN is a Buy.
              What is NOVN’s 200-day moving average?
              NOVN’s 200-day moving average is 92.67, which suggests NOVN is a Buy.
                What is NOVN’s Williams % R (14)?
                NOVN’s Williams % R (14) is -29.03, which suggests NOVN is a Buy.
                  What is NOVN’s CCI (14)?
                  NOVN’s CCI (14) is 42.37, which suggests NOVN is a Neutral.
                    What is the share price of Novartis?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis